Showing results (41-50 of 178) with videos related to

Sort By:
Pageof 18
Hepatology (Baltimore, Md.)|November 26, 2008
Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivoPhilip Meuleman, Joseph Hesselgesser, Matthew Paulson, et al.
Gastroenterology|September 30, 2017
Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid ProteinClaire Montpellier, Czeslaw Wychowski, Ibrahim M Sayed, et al.
Journal of Hepatology|July 2, 2010
Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID miceThomas Vanwolleghem, Louis Libbrecht, Bettina E Hansen, et al.
Viruses|December 23, 2023
Virus-Host Protein Interaction Network of the Hepatitis E Virus ORF2-4 by Mammalian Two-Hybrid AssaysLaura Corneillie, Irma Lemmens, Karin Weening, et al.
Clinical Chemistry|August 1, 2009
uPA+/+-SCID mouse with humanized liver as a model for in vivo metabolism of exogenous steroids: methandienone as a case studyLeen Lootens, Philip Meuleman, Oscar J Pozo, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 11, 2016
Successful Engraftment of Human Hepatocytes in uPA-SCID and FRG® KO MiceLander Foquet, Elizabeth M Wilson, Lieven Verhoye, et al.
Journal of Viral Hepatitis|June 14, 2019
Hepatitis E virus prevalence in Flemish blood donorsAnn-Sofie Vercouter, Freya Van Houtte, Lieven Verhoye, et al.
Frontiers in Microbiology|March 17, 2022
Study of Hepatitis E Virus-4 Infection in Human Liver-Chimeric, Immunodeficient, and Immunocompetent MiceLaura Collignon, Lieven Verhoye, Renate Hakze-Van der Honing, et al.
Advances in Cancer Research|June 21, 2021
Modeling colorectal cancers using multidimensional organoidsIbrahim M Sayed, Amer Ali Abd El-Hafeez, Priti P Maity, et al.
Steroids|January 18, 2016
Metabolic studies of prostanozol with the uPA-SCID chimeric mouse model and human liver microsomesLore Geldof, Leen Lootens, Lieselot Decroix, et al.
Pageof 18